Formycon AG will develop, register, manufacture and supply the product, while Zydus Lifesciences Global FZE, United Arab Emirates will be responsible for the commercialization of FYB206 in the defined territories
While Merck can appeal, Halozyme said it expects the order to hold
Presbyopia, the age-related loss of near vision, could soon be treated successfully
The MUSE system offers a minimally invasive solution for treating gastroesophageal reflux disease
The licence covers Actimed’s existing patents, its proprietary know-how and any future related patents, giving Mankind full control to advance the products under its own brands
EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
The new MimixTM GeniTM reference standards were developed from the extensively tested Genome-in-a-Bottle Consortium (GIAB) cell line
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
